AbstractObjective To analyze the dosimetric differences between 3D printed oral stents and corked oral stents in the target area and perioral organ at risk (OAR) in radiotherapy for head and neck cancer, and the effectiveness in reducing acute adverse reactions associated with radiotherapy. Methods A total of 58 patients with head and neck cancer admitted to Department of Oncology of Affiliated Hospital of North Sichuan Medical College were selected and divided into experimental group (Group A, n=28, wearing 3D printed oral stents during radiotherapy) and control group (Group B, n=30, wearing corked oral stents during radiotherapy) in this retrospective cohort study. The incidence of radiotherapy - induced oral mucositis (RTOM), xerostomia and oropharyngeal mucosal pain was compared between two groups. Meanwhile, informed consent was obtained from 21 patients in Group A. Using the self control method, each patient wore a 3D printed oral stent (Group C) and a corked oral stent (Group D) to make two radiotherapy plans. The differences in the conformity index (CI), homogeneity index (HI) and exposure dose of OAR (Dmax, Dmean) in the target area were analyzed between two groups. SPSS 25.0 statistical software was used for statistical analysis. Measurement data were expressed as Mean±SD. Comparison between two groups was conducted by paired t-test or repeated measurement analysis. Count data were expressed as ratio. Comparison between two groups was performed by Chi - square test or Fisher's exact test. P<0.05 was considered as statistically significant difference. Results The severity of RTOM (P<0.05), oropharyngeal mucosal pain (P=0.004) and xerostomia score (P<0.001) in Group A were significantly lower than those in Group B. There was no significant difference in the HI and CI of the target area between Group C and Group D (both P>0.05). The Dmax (P=0.014, 0.009) and Dmean (P<0.001, P=0.033) of the upper lip and the affected buccal mucosa in Group C were significantly lower than those in Group D. Conclusion 3D printed oral stents obtain favorable HI and CI in radiotherapy for head and neck cancer, significantly reduce the irradiated dose to perioral OAR, and effectively lower the incidence and mitigate the severity of acute RTOM, xerostomia and oropharyngeal mucosal pain associated with radiotherapy.
Fund:Nanchong City-School Science and Technology Strategic Cooperation-National Natural Science Foundation Preliminary Research Project (20SXZRKX0006)
Corresponding Authors:
Tan Bangxian, Email: tbx_nsmc@126.com
Cite this article:
Meng Xue,Du Guobo,Wu Tingting et al. Study of application of 3D printed oral stents in radiotherapy for head and neck malignancies[J]. Chinese Journal of Radiation Oncology, 2023, 32(7): 577-583.
Meng Xue,Du Guobo,Wu Tingting et al. Study of application of 3D printed oral stents in radiotherapy for head and neck malignancies[J]. Chinese Journal of Radiation Oncology, 2023, 32(7): 577-583.
[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338. [2] Lewis-Jones H, Colley S, Gibson D. Imaging in head and neck cancer: United Kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016,130(S2):S28-S31. DOI: 10.1017/S0022215116000396. [3] Jensen SB, Vissink A, Limesand KH, et al. Salivary gland hypofunction and xerostomia in head and neck radiation patients[J]. J Natl Cancer Inst Monogr, 2019,2019(53) :lgz016. DOI: 10.1093/jncimonographs/lgz016. [4] Elting LS, Cooksley CD, Chambers MS, et al. Risk, outcomes,costs of radiation-induced oral mucositis among patients with head-and-neck malignancies[J]. Int J Radiat Oncol Biol Phys, 2007,68(4):1110-1120. DOI: 10.1016/j.ijrobp.2007.01.053. [5] Squires M, Hu Y, Byrne M, et al. Static beam tomotherapy as an optimisation method in whole-breast radiation therapy (WBRT)[J]. J Med Radiat Sci, 2017,64(4):281-289. DOI: 10.1002/jmrs.232. [6] Delishaj D, Ursino S, Pasqualetti F, et al. Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol[J]. Radiat Oncol J, 2018,36(1):54-62. DOI: 10.3857/roj.2017.00493. [7] Klippel N, Schmücking M, Terribilini D, et al. Improved VMAT planning for head and neck tumors with an advanced optimization algorithm[J]. Z Med Phys, 2015,25(4):333-340. DOI: 10.1016/j.zemedi.2015.05.002. [8] Mnejja W, Daoud H, Fourati N, et al. Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma[J]. Rep Pract Oncol Radiother, 2020,25(1):41-45. DOI: 10.1016/j.rpor.2019.12.012. [9] Hermans BC, Persoon LC, Podesta M, et al. Weekly kilovoltage cone-beam computed tomography for detection of dose discrepancies during (chemo)radiotherapy for head and neck cancer[J]. Acta Oncol, 2015,54(9):1483-1489. DOI: 10.3109/0284186X.2015. 1061210. [10] Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) andthe European Organization for Research and Treatment of Cancer (EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995,31(5):1341-1346. DOI: 10.1016/0360-3016(95)00060-C. [11] Alfonsin MM, Chapon R, de Souza C, et al. Correlations among algometry, the visual analogue scale, and the numeric rating scale to assess chronic pelvic pain in women[J]. Eur J Obstet Gynecol Reprod Biol X, 2019,3:100037. DOI: 10.1016/j.eurox.2019.100037. [12] Lastrucci L, Bertocci S, Bini V, et al. Xerostomia quality of life scale (XeQoLS) questionnaire: validation of Italian version in head and neck cancer patients[J]. Radiol Med, 2018,123(1):44-47. DOI: 10.1007/s11547-017-0798-7. [13] 冯振兴. 头颈部肿瘤放疗个体化口含器制作及临床应用[D].天津: 天津医科大学, 2013. Feng ZX.Construction and clinical research of custom-made bite block used in radiation therapy of head and neck cancer[D]. Tianjin: Tianjin Medical University, 2013. [14] 丛薇. 个体化延长型PMMA支架在鼻咽癌放疗中对口腔黏膜的保护效果研究[D]. 青岛: 青岛大学, 2020. Cong W.Study on the protective effect of individual prolonged PMMA stent on oral mucosa in radiotherapy of nasopharyngeal carcinoma[D]. Qingdao: Qingdao University, 2020. [15] Verrone JR, Alves FA, Prado JD, et al. Benefits of an intraoral stent in decreasing the irradiation dose to oral healthy tissue: dosimetric and clinical features[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014,118(5):573-578. DOI: 10.1016/j.oooo.2014.08.008. [16] Inoue Y, Yamagata K, Nakamura M, et al. Are intraoral stents effective for reducing the severity of oral mucositis during radiotherapy for maxillary and nasal cavity cancer?[J]. J Oral Maxillofac Surg, 2020,78(7):1214.e1-1214.e8. DOI: 10.1016/j.joms.2020.02.009. [17] Stieb S, Perez-Martinez I, Mohamed A, et al. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors[J]. Clin Transl Radiat Oncol, 2020,24:71-78. DOI: 10.1016/j.ctro.2020.05.014.
2023, Vol. 32 
